26
Oversold
Moving averages
SMA 200$4.38-86.16%
Company profile
23andMe, Inc., a consumer genetics and research company, is dedicated to developing a genetic database to unlock knowledge that leads to rapid discovery of new drug development targets. The company is headquartered in Sunnyvale, California with an additional office in Mountain View, California.
SectorHealthcare
IndustryDiagnostics & Research
Market cap$13.34M
P/E ratioNone
EPS$-17.39
Beta1.195
Dividend yield0.00%
Similar stocks in Diagnostics & Research
TMO
Thermo Fisher Scientific Inc
RSI 52
ILMN
Illumina Inc
RSI 52
MTD
Mettler-Toledo International Inc
RSI 55
CSTL
Castle Biosciences Inc
RSI 60
FONR
Fonar Corp
RSI 75
CRL
Charles River Laboratories International Inc
RSI 58
BDSX
Biodesix Inc
RSI 51
NTRA
Natera Inc
RSI 59
WGS
GeneDx Holdings Corp - Class A
RSI 61
DGX
Quest Diagnostics Inc
RSI 36
RSI alerts for ME
Get an email the moment 23Andme Holding Co crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 16 August 2026 at 1:46 AM EDT